SNY Sanofi CEO belen garijo: we remain committed to immunology, rare diseases, and vaccines while we look for potentially additional growth

SNY Sanofi CEO belen garijo: we remain committed to immunology, rare diseases, and vaccines while we look for potentially additional growth opportunities - Media call Sanofi CEO notes will continue to complement our internal innovation through disciplined business development and M&A Sanofi CEO notes will continue to expand our presence in China Sanofi CEO notes 'i am no longer in the diagnosis phase' Sanofi CEO notes strategic review of our late Stage pipeline is still ongoing